Head and neck cancer remains a formidable disease entity. Many of the patients with this tumor type present with locally advanced disease, and although treatment options have increased significantly, improving survival, patients with hea...
Providing survivorship care for the over 20 million cancer survivors expected in the United States by 2020 will be a health-care challenge. The anticipated deficit in health-care providers will demand that follow-up care of this populati...
There are no effective early-detection modalities for epithelial ovarian cancer (EOC), the fifth leading cause of cancer death in women. However, the 5-year survival rate for women diagnosed with stage I disease is 90%, demonstrating the...
Case Study
A.R. is a 45-year-old woman who was diagnosed with an infiltrating ductal carcinoma of her right breast (T3N0M0; estrogen- and progesterone-receptor–positive, HER2-negative). She underwent a modified radical mastectomy follow...
